BEDMINSTER, N.J.--(BUSINESS WIRE)--EKR Therapeutics, Inc., a specialty acute-care pharmaceutical company, today announced that its co-founder Richard DeSimone has been recognized as Chief Financial Officer of the Year by the New Jersey Technology Council (NJTC). This prestigious honor was presented to Mr. DeSimone during the NJTC awards ceremony held on Friday, June 12, 2009 to recognize the accomplishments of a select few financial executives from New Jersey and surrounding regions.
